ONTOLOGY REPORT - ANNOTATIONS
Term: celecoxib
Accession: CHEBI:41423
browse the term
Definition: A member of the class of pyrazoles that is 1H-pyrazole which is substituted at positions 1, 3 and 5 by 4-sulfamoylphenyl, trifluoromethyl and p-tolyl groups, respectively. A cyclooxygenase-2 inhibitor, it is used in the treatment of arthritis.
Synonyms: exact_synonym: 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide
related_synonym: C17H14F3N3O2S; Cc1ccc(cc1)-c1cc(nn1-c1ccc(cc1)S(N)(=O)=O)C(F)(F)F; Celebrex; Celebrex (TN); InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25); InChIKey=RZEKVGVHFLEQIL-UHFFFAOYSA-N; celecoxibum; p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
alt_id: CHEBI:3520; CHEBI:41418
xref_casrn: 169590-42-5; 184007-95-2
xref: ChEMBL:118694 "ChEMBL COMPOUND"; ChemIDplus:169590-42-5 "CAS Registry Number"; ChemIDplus:184007-95-2 "CAS Registry Number"; CiteXplore:17983259 "PubMed citation"; CiteXplore:18405470 "PubMed citation"; CiteXplore:19137124 "PubMed citation"; CiteXplore:19203891 "PubMed citation"; CiteXplore:21955617 "PubMed citation"; CiteXplore:22141388 "PubMed citation"; CiteXplore:22419293 "PubMed citation"; CiteXplore:22971036 "PubMed citation"; CiteXplore:23296687 "PubMed citation"; CiteXplore:23506230 "PubMed citation"; DrugBank:DB00482 "DrugBank"; HMDB:HMDB05014 "HMDB"; KEGG COMPOUND:169590-42-5 "CAS Registry Number"; KEGG COMPOUND:C07589 "KEGG COMPOUND"; KEGG DRUG:D00567 "KEGG DRUG"
xref_mesh: MESH:C105934
xref: PDBeChem:CEL "PDBeChem"; Reaxys:8280770 "Reaxys Registry Number"; Wikipedia:Celecoxib "Wikipedia"
celecoxib
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
decreases expression
EXP
7
87,133,179
87,342,639
RGD:6480464
CTD
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
multiple interactions
EXP
7
87,133,179
87,342,639
RGD:6480464
CTD
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
increases expression
EXP
7
87,133,179
87,342,639
RGD:6480464
CTD
G
ABCB1
ATP-binding cassette, sub-family B (MDR/TAP), member 1
increases methylation
EXP
7
87,133,179
87,342,639
RGD:6480464
CTD
G
ABCB11
ATP-binding cassette, sub-family B (MDR/TAP), member 11
decreases activity
EXP
2
169,779,449
169,887,833
RGD:6480464
CTD
G
ABCC1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
increases expression
EXP
16
16,043,434
16,236,931
RGD:6480464
CTD
G
ABCC2
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
decreases activity
EXP
10
101,542,463
101,611,662
RGD:6480464
CTD
G
ABCC4
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
increases expression
EXP
13
95,672,083
95,953,687
RGD:6480464
CTD
G
ABCC5
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
increases expression
EXP
3
183,637,722
183,735,727
RGD:6480464
CTD
G
ABCF1
ATP-binding cassette, sub-family F (GCN20), member 1
affects expression
ISO
6
30,539,170
30,559,309
RGD:6480464
CTD
G
ABCF2
ATP-binding cassette, sub-family F (GCN20), member 2
affects expression
ISO
7
150,904,923
150,924,317
RGD:6480464
CTD
G
ABCG2
ATP-binding cassette, sub-family G (WHITE), member 2
decreases expression
EXP
4
89,011,416
89,152,474
RGD:6480464
CTD
G
ACAN
aggrecan
affects expression
ISO
15
89,346,674
89,418,585
RGD:6480464
CTD
G
ACHE
acetylcholinesterase
increases activity
ISO
7
100,487,615
100,493,541
RGD:6480464
CTD
G
ACHE
acetylcholinesterase
multiple interactions
ISO
7
100,487,615
100,493,541
RGD:6480464
CTD
G
ACHE
acetylcholinesterase
multiple interactions
ISO
7
100,487,615
100,493,541
RGD:6480464
CTD
G
ACHE
acetylcholinesterase
increases activity
ISO
7
100,487,615
100,493,541
RGD:6480464
CTD
G
ACHE
acetylcholinesterase
multiple interactions
ISO
7
100,487,615
100,493,541
RGD:6480464
CTD
G
ACTA2
actin, alpha 2, smooth muscle, aorta
decreases expression
ISO
10
90,694,831
90,751,147
RGD:6480464
CTD
G
ACTA2
actin, alpha 2, smooth muscle, aorta
multiple interactions
ISO
10
90,694,831
90,751,147
RGD:6480464
CTD
G
ACTA2
actin, alpha 2, smooth muscle, aorta
multiple interactions
ISO
10
90,694,831
90,751,147
RGD:6480464
CTD
G
ACTA2
actin, alpha 2, smooth muscle, aorta
decreases expression
ISO
10
90,694,831
90,751,147
RGD:6480464
CTD
G
AKAP1
A kinase (PRKA) anchor protein 1
affects expression
ISO
17
55,162,553
55,198,710
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
multiple interactions
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases response to substance
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
increases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
multiple interactions
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
multiple interactions
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases expression
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
multiple interactions
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
increases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
affects phosphorylation
ISO
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
multiple interactions
ISO
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases expression
ISO
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
multiple interactions
ISO
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases activity
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases phosphorylation
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
AKT1
v-akt murine thymoma viral oncogene homolog 1
decreases response to substance
EXP
14
105,235,686
105,262,080
RGD:6480464
CTD
G
ALDOC
aldolase C, fructose-bisphosphate
affects expression
ISO
17
26,900,133
26,903,951
RGD:6480464
CTD
G
ALOX5
arachidonate 5-lipoxygenase
multiple interactions
ISO
10
45,869,624
45,941,567
RGD:6480464
CTD
G
APAF1
apoptotic peptidase activating factor 1
increases expression
ISO
12
99,039,078
99,129,211
RGD:6480464
CTD
G
APP
amyloid beta (A4) precursor protein
affects cleavage
ISO
21
27,252,861
27,543,446
RGD:6480464
CTD
G
AR
androgen receptor
decreases expression
ISO
X
66,763,874
66,950,461
RGD:6480464
CTD
G
AR
androgen receptor
multiple interactions
ISO
X
66,763,874
66,950,461
RGD:6480464
CTD
G
ATP6AP2
ATPase, H+ transporting, lysosomal accessory protein 2
affects expression
ISO
X
40,440,216
40,465,889
RGD:6480464
CTD
G
ATP9A
ATPase, class II, type 9A
affects expression
ISO
20
50,213,314
50,384,908
RGD:6480464
CTD
G
BAK1
BCL2-antagonist/killer 1
increases expression
EXP
6
33,540,323
33,548,070
RGD:6480464
CTD
G
BAK1
BCL2-antagonist/killer 1
decreases response to substance
ISO
6
33,540,323
33,548,070
RGD:6480464
CTD
G
BAK1
BCL2-antagonist/killer 1
increases expression
EXP
6
33,540,323
33,548,070
RGD:6480464
CTD
G
BAK1
BCL2-antagonist/killer 1
increases expression
EXP
6
33,540,323
33,548,070
RGD:6480464
CTD
G
BAK1
BCL2-antagonist/killer 1
increases expression
EXP
6
33,540,323
33,548,070
RGD:6480464
CTD
G
BAX
BCL2-associated X protein
multiple interactions
EXP
19
49,458,117
49,465,055
RGD:6480464
CTD
G
BAX
BCL2-associated X protein
increases activity
EXP
19
49,458,117
49,465,055
RGD:6480464
CTD
G
BAX
BCL2-associated X protein
multiple interactions
EXP
19
49,458,117
49,465,055
RGD:6480464
CTD
G
BAX
BCL2-associated X protein
increases expression
EXP
19
49,458,117
49,465,055
RGD:6480464
CTD
G
BAX
BCL2-associated X protein
decreases expression
EXP
19
49,458,117
49,465,055
RGD:6480464
CTD
G
BBC3
BCL2 binding component 3
multiple interactions
EXP
19
47,724,079
47,736,023
RGD:6480464
CTD
G
BBC3
BCL2 binding component 3
increases response to substance
EXP
19
47,724,079
47,736,023
RGD:6480464
CTD
G
BBC3
BCL2 binding component 3
increases expression
EXP
19
47,724,079
47,736,023
RGD:6480464
CTD
G
BBC3
BCL2 binding component 3
increases expression
EXP
19
47,724,079
47,736,023
RGD:6480464
CTD
G
BBC3
BCL2 binding component 3
multiple interactions
EXP
19
47,724,079
47,736,023
RGD:6480464
CTD
G
BCAR1
breast cancer anti-estrogen resistance 1
multiple interactions
EXP
16
75,262,928
75,301,951
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
multiple interactions
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
multiple interactions
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
decreases expression
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
multiple interactions
ISO
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
decreases expression
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
increases expression
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
decreases expression
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2
B-cell CLL/lymphoma 2
decreases expression
EXP
18
60,790,579
60,986,613
RGD:6480464
CTD
G
BCL2L1
BCL2-like 1
multiple interactions
EXP
20
30,252,261
30,310,656
RGD:6480464
CTD
G
BCL2L1
BCL2-like 1
multiple interactions
EXP
20
30,252,261
30,310,656
RGD:6480464
CTD
G
BCL2L1
BCL2-like 1
decreases expression
EXP
20
30,252,261
30,310,656
RGD:6480464
CTD
G
BCL2L1
BCL2-like 1
increases expression
EXP
20
30,252,261
30,310,656
RGD:6480464
CTD
G
BID
BH3 interacting domain death agonist
multiple interactions
EXP
22
18,216,906
18,257,431
RGD:6480464
CTD
G
BID
BH3 interacting domain death agonist
increases cleavage
EXP
22
18,216,906
18,257,431
RGD:6480464
CTD
G
BID
BH3 interacting domain death agonist
multiple interactions
EXP
22
18,216,906
18,257,431
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
multiple interactions
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
affects binding
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
increases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
multiple interactions
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
decreases expression
EXP
17
76,210,277
76,221,716
RGD:6480464
CTD
G
BIRC5
baculoviral IAP repeat containing 5
multiple interactions
ISO
17
76,210,277
76,221,716
RGD:6480464
CTD
G
CA2
carbonic anhydrase II
multiple interactions
EXP
8
86,376,131
86,393,721
RGD:6480464
CTD
G
CA3
carbonic anhydrase III, muscle specific
multiple interactions
EXP
8
86,351,056
86,361,269
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases activity
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
decreases expression
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases activity
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases activity
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases cleavage
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases expression
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases activity
ISO
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases expression
ISO
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases activity
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases cleavage
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases activity
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases activity
ISO
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP3
caspase 3, apoptosis-related cysteine peptidase
increases activity
EXP
4
185,548,850
185,570,629
RGD:6480464
CTD
G
CASP6
caspase 6, apoptosis-related cysteine peptidase
multiple interactions
EXP
4
110,609,785
110,624,629
RGD:6480464
CTD
G
CASP7
caspase 7, apoptosis-related cysteine peptidase
increases activity
EXP
10
115,438,921
115,490,668
RGD:6480464
CTD
G
CASP7
caspase 7, apoptosis-related cysteine peptidase
affects activity
EXP
10
115,438,921
115,490,668
RGD:6480464
CTD
G
CASP7
caspase 7, apoptosis-related cysteine peptidase
increases activity
EXP
10
115,438,921
115,490,668
RGD:6480464
CTD
G
CASP7
caspase 7, apoptosis-related cysteine peptidase
multiple interactions
EXP
10
115,438,921
115,490,668
RGD:6480464
CTD
G
CASP8
caspase 8, apoptosis-related cysteine peptidase
multiple interactions
EXP
2
202,098,166
202,152,434
RGD:6480464
CTD
G
CASP8
caspase 8, apoptosis-related cysteine peptidase
increases activity
EXP
2
202,098,166
202,152,434
RGD:6480464
CTD
G
CASP8
caspase 8, apoptosis-related cysteine peptidase
multiple interactions
EXP
2
202,098,166
202,152,434
RGD:6480464
CTD
G
CASP8
caspase 8, apoptosis-related cysteine peptidase
increases cleavage
EXP
2
202,098,166
202,152,434
RGD:6480464
CTD
G
CASP8
caspase 8, apoptosis-related cysteine peptidase
increases activity
EXP
2
202,098,166
202,152,434
RGD:6480464
CTD
G
CASP8
caspase 8, apoptosis-related cysteine peptidase
multiple interactions
EXP
2
202,098,166
202,152,434
RGD:6480464
CTD
G
CASP8
caspase 8, apoptosis-related cysteine peptidase
multiple interactions
EXP
2
202,098,166
202,152,434
RGD:6480464
CTD
G
CASP8
caspase 8, apoptosis-related cysteine peptidase
multiple interactions
EXP
2
202,098,166
202,152,434
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
increases activity
ISO
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
increases activity
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
increases cleavage
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
increases activity
ISO
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
multiple interactions
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
increases cleavage
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CASP9
caspase 9, apoptosis-related cysteine peptidase
increases cleavage
EXP
1
15,818,769
15,851,285
RGD:6480464
CTD
G
CAT
catalase
decreases expression
EXP
11
34,460,472
34,493,607
RGD:6480464
CTD
G
CAT
catalase
multiple interactions
ISO
11
34,460,472
34,493,607
RGD:6480464
CTD
G
CAV1
caveolin 1, caveolae protein, 22kDa
increases expression
EXP
7
116,164,839
116,201,239
RGD:6480464
CTD
G
CCL2
chemokine (C-C motif) ligand 2
decreases expression
ISO
17
32,582,296
32,584,222
RGD:6480464
CTD
G
CCL2
chemokine (C-C motif) ligand 2
multiple interactions
ISO
17
32,582,296
32,584,222
RGD:6480464
CTD
G
CCL5
chemokine (C-C motif) ligand 5
decreases expression
ISO
17
34,198,495
34,207,377
RGD:6480464
CTD
G
CCNB1
cyclin B1
affects expression
EXP
5
68,462,837
68,474,072
RGD:6480464
CTD
G
CCND1
cyclin D1
affects expression
EXP
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CCND1
cyclin D1
multiple interactions
EXP
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CCND1
cyclin D1
multiple interactions
EXP
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CCND1
cyclin D1
decreases expression
EXP
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CCND1
cyclin D1
multiple interactions
ISO
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CCND1
cyclin D1
decreases expression
ISO
11
69,455,873
69,469,242
RGD:6480464
CTD
G
CCND2
cyclin D2
decreases expression
EXP
12
4,382,902
4,414,522
RGD:6480464
CTD
G
CCR2
chemokine (C-C motif) receptor 2
decreases expression
ISO
3
46,395,235
46,402,413
RGD:6480464
CTD
G
CCR5
chemokine (C-C motif) receptor 5 (gene/pseudogene)
decreases expression
ISO
3
46,411,633
46,417,697
RGD:6480464
CTD
G
CD2AP
CD2-associated protein
multiple interactions
ISO
6
47,445,525
47,594,999
RGD:6480464
CTD
G
CDH1
cadherin 1, type 1, E-cadherin (epithelial)
increases expression
EXP
16
68,771,195
68,869,444
RGD:6480464
CTD
G
CDH1
cadherin 1, type 1, E-cadherin (epithelial)
affects expression
EXP
16
68,771,195
68,869,444
RGD:6480464
CTD
G
CDK2
cyclin-dependent kinase 2
decreases expression
EXP
12
56,360,556
56,366,568
RGD:6480464
CTD
G
CDK2
cyclin-dependent kinase 2
decreases expression
EXP
12
56,360,556
56,366,568
RGD:6480464
CTD
G
CDK4
cyclin-dependent kinase 4
decreases expression
EXP
12
58,141,510
58,146,230
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
multiple interactions
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
multiple interactions
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases activity
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases expression
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases expression
ISO
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases expression
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases expression
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases localization
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases expression
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
multiple interactions
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
increases expression
EXP
6
36,644,237
36,655,116
RGD:6480464
CTD
G
CDKN1B
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
multiple interactions
EXP
12
12,870,302
12,875,305
RGD:6480464
CTD
G
CDKN1B
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
multiple interactions
EXP
12
12,870,302
12,875,305
RGD:6480464
CTD
G
CDKN1B
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
increases expression
ISO
12
12,870,302
12,875,305
RGD:6480464
CTD
G
CDKN1B
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
increases expression
EXP
12
12,870,302
12,875,305
RGD:6480464
CTD
G
CDKN1B
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
increases expression
EXP
12
12,870,302
12,875,305
RGD:6480464
CTD
G
CDKN1B
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
increases expression
EXP
12
12,870,302
12,875,305
RGD:6480464
CTD
G
CDKN1B
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
increases expression
EXP
12
12,870,302
12,875,305
RGD:6480464
CTD
G
CEBPA
CCAAT/enhancer binding protein (C/EBP), alpha
multiple interactions
ISO
19
33,790,840
33,793,430
RGD:6480464
CTD
G
CFLAR
CASP8 and FADD-like apoptosis regulator
decreases expression
EXP
2
201,980,877
202,037,411
RGD:6480464
CTD
G
CHUK
conserved helix-loop-helix ubiquitous kinase
multiple interactions
EXP
10
101,948,124
101,989,344
RGD:6480464
CTD
G
COL1A1
collagen, type I, alpha 1
multiple interactions
ISO
17
48,261,457
48,279,000
RGD:6480464
CTD
G
COL1A1
collagen, type I, alpha 1
decreases expression
ISO
17
48,261,457
48,279,000
RGD:6480464
CTD
G
CRP
C-reactive protein, pentraxin-related
decreases expression
EXP
1
159,682,079
159,684,379
RGD:6480464
CTD
G
CRYAB
crystallin, alpha B
multiple interactions
ISO
11
111,779,350
111,782,473
RGD:6480464
CTD
G
CTNNB1
catenin (cadherin-associated protein), beta 1, 88kDa
affects localization
EXP
3
41,240,942
41,281,939
RGD:6480464
CTD
G
CXCR1
chemokine (C-X-C motif) receptor 1
decreases expression
ISO
2
219,027,568
219,031,716
RGD:6480464
CTD
G
CXCR2
chemokine (C-X-C motif) receptor 2
decreases expression
ISO
2
218,990,013
219,001,976
RGD:6480464
CTD
G
CYP19A1
cytochrome P450, family 19, subfamily A, polypeptide 1
decreases activity
EXP
15
51,500,254
51,630,795
RGD:6480464
CTD
G
CYP19A1
cytochrome P450, family 19, subfamily A, polypeptide 1
decreases expression
EXP
15
51,500,254
51,630,795
RGD:6480464
CTD
G
CYP1A2
cytochrome P450, family 1, subfamily A, polypeptide 2
decreases activity
EXP
15
75,041,184
75,048,941
RGD:6480464
CTD
G
CYP2C9
cytochrome P450, family 2, subfamily C, polypeptide 9
increases metabolic processing
EXP
10
96,698,415
96,749,148
RGD:6480464
CTD
G
CYP2C9
cytochrome P450, family 2, subfamily C, polypeptide 9
increases metabolic processing
EXP
10
96,698,415
96,749,148
RGD:6480464
CTD
G
DAP3
death associated protein 3
affects expression
ISO
1
155,658,882
155,708,801
RGD:6480464
CTD
G
DDIT3
DNA-damage-inducible transcript 3
affects expression
EXP
12
57,910,371
57,914,300
RGD:6480464
CTD
G
DDIT3
DNA-damage-inducible transcript 3
increases expression
EXP
12
57,910,371
57,914,300
RGD:6480464
CTD
G
DDIT3
DNA-damage-inducible transcript 3
increases expression
EXP
12
57,910,371
57,914,300
RGD:6480464
CTD
G
DDIT3
DNA-damage-inducible transcript 3
multiple interactions
EXP
12
57,910,371
57,914,300
RGD:6480464
CTD
G
DDIT3
DNA-damage-inducible transcript 3
increases expression
EXP
12
57,910,371
57,914,300
RGD:6480464
CTD
G
DES
desmin
increases expression
EXP
2
220,283,099
220,291,461
RGD:6480464
CTD
G
DES
desmin
multiple interactions
EXP
2
220,283,099
220,291,461
RGD:6480464
CTD
G
DFFA
DNA fragmentation factor, 45kDa, alpha polypeptide
multiple interactions
EXP
1
10,520,588
10,532,613
RGD:6480464
CTD
G
DHCR24
24-dehydrocholesterol reductase
affects expression
ISO
1
55,315,300
55,352,921
RGD:6480464
CTD
G
EGFR
epidermal growth factor receptor
multiple interactions
ISO
7
55,086,725
55,275,031
RGD:6480464
CTD
G
EGFR
epidermal growth factor receptor
multiple interactions
ISO
7
55,086,725
55,275,031
RGD:6480464
CTD
G
EMC3
ER membrane protein complex subunit 3
affects expression
ISO
3
10,005,636
10,028,522
RGD:6480464
CTD
G
FADD
Fas (TNFRSF6)-associated via death domain
multiple interactions
EXP
11
70,049,269
70,053,508
RGD:6480464
CTD
G
FADD
Fas (TNFRSF6)-associated via death domain
multiple interactions
EXP
11
70,049,269
70,053,508
RGD:6480464
CTD
G
FADD
Fas (TNFRSF6)-associated via death domain
affects response to substance
EXP
11
70,049,269
70,053,508
RGD:6480464
CTD
G
FAS
Fas (TNF receptor superfamily, member 6)
increases expression
EXP
10
90,750,288
90,775,542
RGD:6480464
CTD
G
FAS
Fas (TNF receptor superfamily, member 6)
multiple interactions
EXP
10
90,750,288
90,775,542
RGD:6480464
CTD
G
FAS
Fas (TNF receptor superfamily, member 6)
increases expression
EXP
10
90,750,288
90,775,542
RGD:6480464
CTD
G
FASN
fatty acid synthase
decreases activity
ISO
17
80,036,214
80,056,106
RGD:6480464
CTD
G
FASN
fatty acid synthase
multiple interactions
ISO
17
80,036,214
80,056,106
RGD:6480464
CTD
G
FOS
FBJ murine osteosarcoma viral oncogene homolog
affects expression
ISO
14
75,745,481
75,748,937
RGD:6480464
CTD
G
FOS
FBJ murine osteosarcoma viral oncogene homolog
decreases expression
ISO
14
75,745,481
75,748,937
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
increases expression
EXP
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
multiple interactions
EXP
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
multiple interactions
EXP
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
increases expression
EXP
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
increases expression
EXP
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
multiple interactions
EXP
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
increases expression
EXP
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
increases expression
EXP
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GDF15
growth differentiation factor 15
increases expression
EXP
19
18,496,968
18,499,986
RGD:6480464
CTD
G
GORASP2
golgi reassembly stacking protein 2, 55kDa
affects expression
ISO
2
171,784,948
171,823,645
RGD:6480464
CTD
G
GPX1
glutathione peroxidase 1
increases expression
ISO
3
49,394,609
49,395,791
RGD:6480464
CTD
G
GRIA1
glutamate receptor, ionotropic, AMPA 1
multiple interactions
ISO
5
152,870,084
153,193,429
RGD:6480464
CTD
G
GRIA2
glutamate receptor, ionotropic, AMPA 2
multiple interactions
ISO
4
158,141,736
158,287,227
RGD:6480464
CTD
G
GRIA3
glutamate receptor, ionotropic, AMPA 3
multiple interactions
ISO
X
122,318,096
122,624,766
RGD:6480464
CTD
G
GRIA4
glutamate receptor, ionotropic, AMPA 4
multiple interactions
ISO
11
105,480,800
105,852,819
RGD:6480464
CTD
G
GRIK1
glutamate receptor, ionotropic, kainate 1
multiple interactions
ISO
21
30,909,254
31,312,282
RGD:6480464
CTD
G
GRIK2
glutamate receptor, ionotropic, kainate 2
multiple interactions
ISO
6
101,846,861
102,517,958
RGD:6480464
CTD
G
GRIK3
glutamate receptor, ionotropic, kainate 3
multiple interactions
ISO
1
37,261,128
37,499,844
RGD:6480464
CTD
G
GRIK4
glutamate receptor, ionotropic, kainate 4
multiple interactions
ISO
11
120,531,028
120,856,969
RGD:6480464
CTD
G
GRIK5
glutamate receptor, ionotropic, kainate 5
multiple interactions
ISO
19
42,502,468
42,569,957
RGD:6480464
CTD
G
GRIN1
glutamate receptor, ionotropic, N-methyl D-aspartate 1
multiple interactions
ISO
9
140,033,609
140,063,214
RGD:6480464
CTD
G
GRIN2A
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
multiple interactions
ISO
16
9,847,265
10,276,611
RGD:6480464
CTD
G
GRIN2B
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
multiple interactions
ISO
12
13,714,410
14,133,022
RGD:6480464
CTD
G
GRIN2C
glutamate receptor, ionotropic, N-methyl D-aspartate 2C
multiple interactions
ISO
17
72,838,168
72,856,007
RGD:6480464
CTD
G
GRIN2D
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
multiple interactions
ISO
19
48,898,132
48,948,188
RGD:6480464
CTD
G
GRIN3A
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A
multiple interactions
ISO
9
104,331,634
104,500,862
RGD:6480464
CTD
G
GRIN3B
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B
multiple interactions
ISO
19
1,000,437
1,009,723
RGD:6480464
CTD
G
GSK3B
glycogen synthase kinase 3 beta
decreases phosphorylation
EXP
3
119,540,800
119,813,264
RGD:6480464
CTD
G
GSK3B
glycogen synthase kinase 3 beta
multiple interactions
EXP
3
119,540,800
119,813,264
RGD:6480464
CTD
G
GSS
glutathione synthetase
affects expression
ISO
20
33,516,236
33,543,601
RGD:6480464
CTD
G
GSTP1
glutathione S-transferase pi 1
increases expression
EXP
11
67,351,066
67,354,124
RGD:6480464
CTD
G
GSTP1
glutathione S-transferase pi 1
multiple interactions
EXP
11
67,351,066
67,354,124
RGD:6480464
CTD
G
H2AFX
H2A histone family, member X
multiple interactions
EXP
11
118,964,584
118,966,177
RGD:6480464
CTD
G
HMOX1
heme oxygenase (decycling) 1
increases expression
ISO
22
35,777,060
35,790,207
RGD:6480464
CTD
G
HSPA5
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
increases expression
EXP
9
127,997,127
128,003,666
RGD:6480464
CTD
G
IL10
interleukin 10
multiple interactions
ISO
1
206,940,948
206,945,839
RGD:6480464
CTD
G
IL1B
interleukin 1, beta
multiple interactions
EXP
2
113,587,337
113,594,356
RGD:6480464
CTD
G
IL1B
interleukin 1, beta
multiple interactions
ISO
2
113,587,337
113,594,356
RGD:6480464
CTD
G
IL1B
interleukin 1, beta
multiple interactions
ISO
2
113,587,337
113,594,356
RGD:6480464
CTD
G
IL1B
interleukin 1, beta
multiple interactions
ISO
2
113,587,337
113,594,356
RGD:6480464
CTD
G
IL1B
interleukin 1, beta
multiple interactions
ISO
2
113,587,337
113,594,356
RGD:6480464
CTD
G
IL6
interleukin 6 (interferon, beta 2)
multiple interactions
EXP
7
22,766,766
22,771,621
RGD:6480464
CTD
G
IL8
interleukin 8
increases expression
EXP
4
74,606,223
74,609,433
RGD:6480464
CTD
G
JUN
jun proto-oncogene
multiple interactions
EXP
1
59,246,463
59,249,785
RGD:6480464
CTD
G
KDELC1
KDEL (Lys-Asp-Glu-Leu) containing 1
affects expression
ISO
13
103,436,631
103,451,404
RGD:6480464
CTD
G
LCT
lactase
increases activity
ISO
2
136,545,415
136,594,750
RGD:6480464
CTD
G
MAP1LC3B
microtubule-associated protein 1 light chain 3 beta
multiple interactions
EXP
16
87,425,801
87,438,380
RGD:6480464
CTD
G
MAP2K1
mitogen-activated protein kinase kinase 1
decreases phosphorylation
EXP
15
66,679,211
66,783,882
RGD:6480464
CTD
G
MAP2K2
mitogen-activated protein kinase kinase 2
decreases phosphorylation
EXP
19
4,090,319
4,124,126
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation
EXP
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation
EXP
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation
EXP
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
ISO
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
ISO
22
22,113,946
22,221,970
RGD:6480464
CTD
G
MAPK14
mitogen-activated protein kinase 14
multiple interactions
EXP
6
35,995,454
36,079,013
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation
EXP
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
increases phosphorylation
EXP
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
EXP
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions
ISO
16
30,125,426
30,134,630
RGD:6480464
CTD
G
MAPK8
mitogen-activated protein kinase 8
multiple interactions
EXP
10
49,609,687
49,643,183
RGD:6480464
CTD
G
MCL1
myeloid cell leukemia sequence 1 (BCL2-related)
decreases expression
EXP
1
150,547,027
150,552,214
RGD:6480464
CTD
G
MCL1
myeloid cell leukemia sequence 1 (BCL2-related)
decreases expression
EXP
1
150,547,027
150,552,214
RGD:6480464
CTD
G
MCL1
myeloid cell leukemia sequence 1 (BCL2-related)
decreases expression
EXP
1
150,547,027
150,552,214
RGD:6480464
CTD
G
MCL1
myeloid cell leukemia sequence 1 (BCL2-related)
decreases expression
EXP
1
150,547,027
150,552,214
RGD:6480464
CTD
G
MCL1
myeloid cell leukemia sequence 1 (BCL2-related)
decreases expression
EXP
1
150,547,027
150,552,214
RGD:6480464
CTD
G
MCL1
myeloid cell leukemia sequence 1 (BCL2-related)
decreases expression
EXP
1
150,547,027
150,552,214
RGD:6480464
CTD
G
MCL1
myeloid cell leukemia sequence 1 (BCL2-related)
decreases expression
EXP
1
150,547,027
150,552,214
RGD:6480464
CTD
G
MET
met proto-oncogene (hepatocyte growth factor receptor)
multiple interactions
ISO
7
116,312,459
116,438,440
RGD:6480464
CTD
G
MKI67
antigen identified by monoclonal antibody Ki-67
multiple interactions
EXP
10
129,894,923
129,924,468
RGD:6480464
CTD
G
MKI67
antigen identified by monoclonal antibody Ki-67
decreases expression
EXP
10
129,894,923
129,924,468
RGD:6480464
CTD
G
MMP2
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
affects expression
EXP
16
55,513,081
55,540,586
RGD:6480464
CTD
G
MMP2
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
multiple interactions
ISO
16
55,513,081
55,540,586
RGD:6480464
CTD
G
MMP2
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
multiple interactions
EXP
16
55,513,081
55,540,586
RGD:6480464
CTD
G
MMP9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
multiple interactions
ISO
20
44,637,547
44,645,200
RGD:6480464
CTD
G
MMP9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
multiple interactions
ISO
20
44,637,547
44,645,200
RGD:6480464
CTD
G
MPO
myeloperoxidase
increases activity
ISO
17
56,347,217
56,358,296
RGD:6480464
CTD
G
MPO
myeloperoxidase
multiple interactions
ISO
17
56,347,217
56,358,296
RGD:6480464
CTD
G
MRPS26
mitochondrial ribosomal protein S26
affects expression
ISO
20
3,026,675
3,028,896
RGD:6480464
CTD
G
MTUS1
microtubule associated tumor suppressor 1
affects expression
ISO
8
17,501,303
17,658,426
RGD:6480464
CTD
G
MVD
mevalonate (diphospho) decarboxylase
decreases expression
EXP
16
88,718,348
88,729,495
RGD:6480464
CTD
G
MYC
v-myc myelocytomatosis viral oncogene homolog (avian)
decreases expression
EXP
8
128,748,315
128,753,680
RGD:6480464
CTD
G
NFKB1
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
multiple interactions
EXP
4
103,422,486
103,538,459
RGD:6480464
CTD
G
NFKBIA
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
multiple interactions
EXP
14
35,870,716
35,873,960
RGD:6480464
CTD
G
NGFR
nerve growth factor receptor
increases expression
EXP
17
47,572,655
47,592,382
RGD:6480464
CTD
G
NOS2
nitric oxide synthase 2, inducible
multiple interactions
ISO
17
26,083,792
26,127,555
RGD:6480464
CTD
G
NPHS1
nephrosis 1, congenital, Finnish type (nephrin)
multiple interactions
ISO
19
36,316,274
36,342,895
RGD:6480464
CTD
G
NR3C1
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
multiple interactions
ISO
5
142,657,496
142,815,077
RGD:6480464
CTD
G
NRG1
neuregulin 1
multiple interactions
EXP
8
31,496,820
32,622,558
RGD:6480464
CTD
G
OXA1L
oxidase (cytochrome c) assembly 1-like
affects expression
ISO
14
23,235,731
23,240,998
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases cleavage
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
affects cleavage
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases cleavage
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases activity
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
multiple interactions
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases cleavage
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases cleavage
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases cleavage
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases cleavage
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PARP1
poly (ADP-ribose) polymerase 1
increases cleavage
EXP
1
226,548,392
226,595,801
RGD:6480464
CTD
G
PCNA
proliferating cell nuclear antigen
decreases expression
ISO
20
5,095,599
5,107,268
RGD:6480464
CTD
G
PDGFA
platelet-derived growth factor alpha polypeptide
multiple interactions
EXP
7
536,895
559,481
RGD:6480464
CTD
G
PDGFA
platelet-derived growth factor alpha polypeptide
multiple interactions
ISO
7
536,895
559,481
RGD:6480464
CTD
G
PDPK1
3-phosphoinositide dependent protein kinase-1
decreases activity
EXP
16
2,587,965
2,653,191
RGD:6480464
CTD
G
PDPK1
3-phosphoinositide dependent protein kinase-1
multiple interactions
EXP
16
2,587,965
2,653,191
RGD:6480464
CTD
G
PDPK1
3-phosphoinositide dependent protein kinase-1
decreases activity
EXP
16
2,587,965
2,653,191
RGD:6480464
CTD
G
PDPN
podoplanin
decreases expression
EXP
1
13,910,252
13,944,452
RGD:6480464
CTD
G
PIK3C3
phosphatidylinositol 3-kinase, catalytic subunit type 3
multiple interactions
EXP
18
39,535,199
39,661,448
RGD:6480464
CTD
G
PLA2G4A
phospholipase A2, group IVA (cytosolic, calcium-dependent)
multiple interactions
ISO
1
186,798,032
186,958,113
RGD:6480464
CTD
G
PLA2G4A
phospholipase A2, group IVA (cytosolic, calcium-dependent)
multiple interactions
ISO
1
186,798,032
186,958,113
RGD:6480464
CTD
G
PLIN2
perilipin 2
increases expression
EXP
9
19,115,759
19,127,604
RGD:6480464
CTD
G
PMAIP1
phorbol-12-myristate-13-acetate-induced protein 1
increases response to substance
EXP
18
57,567,192
57,571,538
RGD:6480464
CTD
G
POMC
proopiomelanocortin
multiple interactions
ISO
2
25,383,722
25,391,559
RGD:6480464
CTD
G
PPARA
peroxisome proliferator-activated receptor alpha
increases expression
EXP
22
46,546,499
46,639,653
RGD:6480464
CTD
G
PPARD
peroxisome proliferator-activated receptor delta
decreases expression
EXP
6
35,310,335
35,395,968
RGD:6480464
CTD
G
PPARG
peroxisome proliferator-activated receptor gamma
multiple interactions
EXP
3
12,329,349
12,475,855
RGD:6480464
CTD
G
PPARG
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
3
12,329,349
12,475,855
RGD:6480464
CTD
G
PPARG
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
3
12,329,349
12,475,855
RGD:6480464
CTD
G
PPARG
peroxisome proliferator-activated receptor gamma
increases expression
ISO
3
12,329,349
12,475,855
RGD:6480464
CTD
G
PTGER1
prostaglandin E receptor 1 (subtype EP1), 42kDa
multiple interactions
ISO
19
14,583,278
14,586,174
RGD:6480464
CTD
G
PTGES
prostaglandin E synthase
decreases expression
ISO
9
132,500,615
132,515,344
RGD:6480464
CTD
G
PTGES
prostaglandin E synthase
multiple interactions
ISO
9
132,500,615
132,515,344
RGD:6480464
CTD
G
PTGS1
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
9
125,132,809
125,157,982
RGD:6480464
CTD
G
PTGS1
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
9
125,132,809
125,157,982
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
increases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
increases response to substance
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases expression
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
decreases activity
ISO
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PTGS2
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
multiple interactions
EXP
1
186,640,944
186,649,559
RGD:6480464
CTD
G
PXK
PX domain containing serine/threonine kinase
affects expression
ISO
3
58,318,617
58,410,878
RGD:6480464
CTD
G
RB1
retinoblastoma 1
multiple interactions
EXP
13
48,877,883
49,056,026
RGD:6480464
CTD
G
RB1
retinoblastoma 1
increases expression
EXP
13
48,877,883
49,056,026
RGD:6480464
CTD
G
RB1
retinoblastoma 1
increases expression
ISO
13
48,877,883
49,056,026
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
EXP
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
EXP
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
EXP
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
decreases expression
EXP
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
decreases expression
ISO
11
65,421,067
65,430,443
RGD:6480464
CTD
G
RELA
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
decreases expression
ISO
11
65,421,067
65,430,443
RGD:6480464
CTD
G
REN
renin
decreases expression
ISO
1
204,123,944
204,135,465
RGD:6480464
CTD
G
RHOA
ras homolog family member A
multiple interactions
EXP
3
49,396,578
49,449,526
RGD:6480464
CTD
G
RHOB
ras homolog family member B
multiple interactions
EXP
2
20,646,835
20,649,201
RGD:6480464
CTD
G
RHOC
ras homolog family member C
multiple interactions
EXP
1
113,243,749
113,250,025
RGD:6480464
CTD
G
SEC23A
Sec23 homolog A (S. cerevisiae)
affects expression
ISO
14
39,501,123
39,572,437
RGD:6480464
CTD
G
SERPINH1
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
multiple interactions
ISO
11
75,273,101
75,283,849
RGD:6480464
CTD
G
SI
sucrase-isomaltase (alpha-glucosidase)
increases activity
ISO
3
164,696,686
164,796,283
RGD:6480464
CTD
G
SLC2A1
solute carrier family 2 (facilitated glucose transporter), member 1
increases expression
EXP
1
43,391,046
43,424,847
RGD:6480464
CTD
G
SLC31A1
solute carrier family 31 (copper transporters), member 1
decreases expression
EXP
9
115,983,808
116,026,772
RGD:6480464
CTD
G
SLC31A1
solute carrier family 31 (copper transporters), member 1
multiple interactions
EXP
9
115,983,808
116,026,772
RGD:6480464
CTD
G
SLC31A1
solute carrier family 31 (copper transporters), member 1
affects expression
ISO
9
115,983,808
116,026,772
RGD:6480464
CTD
G
SOD1
superoxide dismutase 1, soluble
multiple interactions
ISO
21
33,031,935
33,041,244
RGD:6480464
CTD
G
SOD2
superoxide dismutase 2, mitochondrial
decreases expression
EXP
6
160,100,148
160,114,353
RGD:6480464
CTD
G
SPP1
secreted phosphoprotein 1
multiple interactions
ISO
4
88,896,802
88,904,563
RGD:6480464
CTD
G
SQSTM1
sequestosome 1
multiple interactions
EXP
5
179,233,388
179,265,078
RGD:6480464
CTD
G
SSTR2
somatostatin receptor 2
increases expression
EXP
17
71,161,160
71,168,094
RGD:6480464
CTD
G
STAT3
signal transducer and activator of transcription 3 (acute-phase response factor)
multiple interactions
ISO
17
40,465,343
40,540,513
RGD:6480464
CTD
G
STS
steroid sulfatase (microsomal), isozyme S
multiple interactions
EXP
X
7,137,472
7,272,682
RGD:6480464
CTD
G
SULT2A1
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
affects activity
EXP
19
48,373,723
48,389,654
RGD:6480464
CTD
G
SULT2A1
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
multiple interactions
EXP
19
48,373,723
48,389,654
RGD:6480464
CTD
G
TGFA
transforming growth factor, alpha
multiple interactions
ISO
2
70,674,412
70,781,147
RGD:6480464
CTD
G
TGFB1
transforming growth factor, beta 1
decreases expression
ISO
19
41,836,812
41,859,831
RGD:6480464
CTD
G
TGFB1
transforming growth factor, beta 1
multiple interactions
ISO
19
41,836,812
41,859,831
RGD:6480464
CTD
G
TIMP2
TIMP metallopeptidase inhibitor 2
multiple interactions
ISO
17
76,849,059
76,921,472
RGD:6480464
CTD
G
TM9SF4
transmembrane 9 superfamily protein member 4
affects expression
ISO
20
30,697,309
30,755,061
RGD:6480464
CTD
G
TMEM131
transmembrane protein 131
affects expression
ISO
2
98,372,799
98,612,354
RGD:6480464
CTD
G
TMEM66
transmembrane protein 66
affects expression
ISO
8
29,920,631
29,940,649
RGD:6480464
CTD
G
TMX2
thioredoxin-related transmembrane protein 2
affects expression
ISO
11
57,479,995
57,508,445
RGD:6480464
CTD
G
TMX2
thioredoxin-related transmembrane protein 2
affects expression
ISO
11
57,479,995
57,508,445
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
ISO
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
ISO
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
ISO
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
ISO
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
ISO
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
decreases expression
ISO
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
EXP
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
EXP
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
ISO
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNF
tumor necrosis factor
multiple interactions
ISO
6
31,543,344
31,546,113
RGD:6480464
CTD
G
TNFRSF10A
tumor necrosis factor receptor superfamily, member 10a
increases expression
EXP
8
23,048,970
23,082,680
RGD:6480464
CTD
G
TNFRSF10B
tumor necrosis factor receptor superfamily, member 10b
increases expression
EXP
8
22,877,646
22,926,700
RGD:6480464
CTD
G
TNFRSF10B
tumor necrosis factor receptor superfamily, member 10b
multiple interactions
EXP
8
22,877,646
22,926,700
RGD:6480464
CTD
G
TNFRSF10B
tumor necrosis factor receptor superfamily, member 10b
affects response to substance
EXP
8
22,877,646
22,926,700
RGD:6480464
CTD
G
TNFRSF11B
tumor necrosis factor receptor superfamily, member 11b
increases expression
EXP
8
119,935,796
119,964,383
RGD:6480464
CTD
G
TNFRSF11B
tumor necrosis factor receptor superfamily, member 11b
decreases secretion
EXP
8
119,935,796
119,964,383
RGD:6480464
CTD
G
TNFSF10
tumor necrosis factor (ligand) superfamily, member 10
multiple interactions
EXP
3
172,223,298
172,241,297
RGD:6480464
CTD
G
TP53
tumor protein p53
multiple interactions
EXP
17
7,571,720
7,590,868
RGD:6480464
CTD
G
TP53
tumor protein p53
increases expression
EXP
17
7,571,720
7,590,868
RGD:6480464
CTD
G
TP53
tumor protein p53
multiple interactions
ISO
17
7,571,720
7,590,868
RGD:6480464
CTD
G
TP53
tumor protein p53
multiple interactions
ISO
17
7,571,720
7,590,868
RGD:6480464
CTD
G
TP53
tumor protein p53
multiple interactions
EXP
17
7,571,720
7,590,868
RGD:6480464
CTD
G
TP53
tumor protein p53
increases expression
EXP
17
7,571,720
7,590,868
RGD:6480464
CTD
G
TP53
tumor protein p53
increases response to substance
EXP
17
7,571,720
7,590,868
RGD:6480464
CTD
G
TP53
tumor protein p53
multiple interactions
EXP
17
7,571,720
7,590,868
RGD:6480464
CTD
G
VAPB
VAMP (vesicle-associated membrane protein)-associated protein B and C
affects expression
ISO
20
56,964,175
57,026,157
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
affects expression
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
decreases expression
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
decreases expression
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
increases expression
EXP
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
multiple interactions
ISO
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
multiple interactions
ISO
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
decreases expression
ISO
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
decreases expression
ISO
6
43,737,946
43,754,224
RGD:6480464
CTD
G
VEGFA
vascular endothelial growth factor A
multiple interactions
ISO
6
43,737,946
43,754,224
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest